Our Company Our Markets Our Businesses For Investors For Media For Potential Employees

• Investor Overview
• Stock Info
  • Stock Quote
  • Historical Price Lookup
  • Investment Calculator
  • Dividend Info
• Financial Reports
  • Archives
  • SEDAR
  • EDGAR
• Calendar of Events
• News Releases
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
• Webcasts & Presentations
• Directors & Management
  • Board of Directors
  • Executive Management Team
• Corporate Governance
  • Annual Report
  • Proxy Circular
  • Board of Directors
  • Compensation of Directors
  • Board and Committee Charters
  • Guidelines & Practices
  • Disclosure Required by Section 303A.11 of NYSE
• Global Business Practice Standards
• Frequently Asked Questions
  • General Investor FAQs
• Investor Kit
• Investor Relations Contacts

CONTACT US

Investor Information

121.6 million shares outstanding
(June 30, 2008)

Market cap of C$ 2.02 billion
(June 30, 2008)

Investor Links

2008 Q2 Interim Report

2008 Q2 Investor Fact Sheet

2007 Annual Report PDF

Subscribe to Email Alert

Contact MDS IR

2007 Substantial Issuer Bid

As announced on October 5, 2006, MDS plans to use CAD$500 million of the proceeds from the sale of the MDS Diagnostics Services business to fund a substantial issuer bid in the form of a Dutch auction after the close of the MDS Diagnostic Services transaction. 

More details will be available on this page and in the Frequently Asked Question section of this website to help investors understand how they may participate in the substantial issuer bid when it is initiated and who to contact for more information.